193NM LIMITED

Executive Summary

193NM LIMITED presents a low financial risk, supported by strong liquidity and equity growth, with no overdue filings or insolvency indicators. Key concerns include significant director creditor balances and rising tax liabilities, warranting further review. Overall, the company appears financially stable within its specialized medical practice sector, with sound regulatory compliance.

193NM LIMITED - Analysis Report

Company Number: 13091230

Analysis Date: 2025-07-20 18:58 UTC

1. Risk Rating: LOW
   The company demonstrates strong net current assets and shareholder funds with no overdue filings or signs of insolvency. Financial data indicates growing cash reserves and positive equity, supporting a low solvency risk profile.

2. Key Concerns:

• Directors’ current account creditor balance (£75,149) is significant and should be understood in terms of repayment terms and impact on liquidity.
• Corporation tax creditor has increased notably (£89,613), suggesting potential upcoming cash outflows that require monitoring.
• Limited information on turnover, profitability, and cash flow beyond balance sheet limits full assessment of operational performance and sustainability.

3. Positive Indicators:

• Substantial increase in cash reserves from £167k in 2022 to £458k in 2023, indicating strong liquidity.
• Net current assets growth from £61k to £292k and equity increase from £66k to £317k in the latest year reflect a robust financial position.
• Timely submission of accounts and confirmation statements, showing good regulatory compliance.
• Company operates in a specialized medical practice sector (SIC 86220), typically associated with stable demand and skilled professional services.

4. Due Diligence Notes:

• Clarify nature, terms, and expected repayment schedule of director’s current account balance classified as a creditor.
• Review corporation tax liabilities and confirm payment plans or potential disputes.
• Obtain management accounts or profit and loss statements to assess revenue trends and profitability beyond balance sheet analysis.
• Verify if the recent appointment of a new director has led to any strategic or operational changes.
• Confirm absence of any director disqualifications or regulatory issues beyond Companies House filings.